Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. (8th October 2021)

• Record Type: Journal Article
• Authors: Hakam, Abeer Essam; Duarte, Poliana Mendes; Mbadu, Marcia Phemba; Aukhil, Ikramuddin; da Silva, Hélio Doyle Pereira; Chang, Jia
• Is Part Of: Journal of periodontal research. Volume 57:Number 1(2022)
• Page Start: 75
• Page End: 84
• Publication Date: 2021-10-08
• Subjects: atypical antidepressants -- atypical antidepressants -- monoamine oxidase inhibitors -- periodontitis -- selective serotonin reuptake inhibitors -- serotonin and noradrenaline reuptake inhibitors; Periodontics -- Periodicals; 617.632
• DOI: 10.1111/jre.12939
• Languages: English
• ISSNs: 0022-3484

Abstract

Abstract: Objective: Our study aimed to determine the relationship of antidepressant medicine use with periodontal diseases, exploring the association of different pharmacological classes of antidepressant with observations of clinical attachment loss (CAL) and alveolar bone level (BL) in patients with periodontitis. Background: Existing evidence on the impact of antidepressant medication on periodontal tissues has focused on some classes only and is still unclear. Therefore, this retrospective study evaluated the association of different antidepressant classes with clinical attachment loss (CAL) and alveolar bone level (BL). Methods: This study was carried out in a population of patients aged ≥ 30 years old with periodontitis who sought treatment at the University of Florida from 2014 to 2018. The following variables were obtained from patients' records; usage of antidepressant medications and their pharmacological classes (selective serotonin reuptake inhibitors [SSRI], serotonin‐norepinephrine reuptake inhibitors [SNRI], tricyclic, atypical, and monoamine oxidase inhibitors [MAO]), age, gender, smoking habit, mild systemic diseases, CAL, and cement‐enamel junction (CEJ) and alveolar bone crest (BC) distance, defined as BL, in the Ramfjord index teeth. Results: Five hundred and eighty‐two periodontitis patients were evaluated, of which 113 (19.4%) were antidepressant users. Antidepressant users exhibited significantly lower BL and fewer sites with severe CAL (≥5 mm), than non‐users ( p < .05). Among all single‐class antidepressant users, the SSRI users showed significantly less CAL and lower BL than non‐users ( p < .05). Patients taking combinations of the different classes of antidepressants also showed better CAL and BL than non‐users. Generalized linear models, including variables such as gender, age, systemic diseases, and smoking, demonstrated that antidepressant users were more likely to have lower mean BL and fewer sites with severe bone loss (i.e. BL > 3 and >5 mm) than non‐users ( p < .05). Conclusions: Antidepressant medications were associated with higher alveolar bone level and less clinical attachment loss in patients with periodontitis. When the different classes of antidepressants were analyzed individually, only the SSRI class users and the multiple‐class users showed significantly less periodontal breakdown than non‐users.